Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/88428
Title: Therapeutic management with the newer antiepileptic drugs in Malta
Authors: Mifsud, Janet
Buttigieg, A.
Debono, A. G.
Micallef, R. E.
Keywords: Epilepsy -- Treatment -- Malta
Epileptics -- Care
Anticonvulsants -- Malta
Issue Date: 1999-02
Publisher: John Wiley & Sons, Inc.
Citation: Mifsud, J., Buttigieg, A., Debono, A. G., & Micallef, R. E. (1999). Therapeutic management with the newer antiepileptic drugs in Malta. Epilepsia, 40(s2), 96.
Abstract: INTRODUCTION: Epilepsy has an estimated incidence of 1800 patients in Malta, which has a population of 370,000. In the last 5 years, three of the newer antiepileptic drugs (AEDs) were approved for use within the health services in Malta. Due to limited economic resources, a study was carried out in order to determine whether increased costs were offset by an improvement in the management of epilepsy in a small island population.
METHODS: Following approval by the Ethics Committee, a total of 113 adult patients with epilepsy satisfied the inclusion criteria for the study and were recruited from the Outpatients Department, St Luke’s Hospital. Fifty one patients were on newer AED treatment as adjunct therapy while 62 were on traditional AED therapy alone. Of the former, 34 had received vigabatrin, 29 lamotrigine and 5 had received gabapentin at some stage. The data was analysed using a Pearson Chi-Squared statistical method.
[excerpt]
URI: https://www.um.edu.mt/library/oar/handle/123456789/88428
Appears in Collections:Scholarly Works - FacM&SCPT

Files in This Item:
File Description SizeFormat 
Therapeutic management with the newer antiepileptic drugs in Malta.pdf
  Restricted Access
152.46 kBAdobe PDFView/Open Request a copy


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.